Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,640,284
+$17,487,658 QoQ
Shares Held
4,258,668
+1.3% QoQ
Ownership
5.90%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 158 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,039,430,805 across 359 Biotechnology names. FDMT ranks #59 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in FDMT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,640,284 | 4,258,668 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $39,152,626 | 4,205,438 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,271,786 | 4,302,905 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $35,875,934 | 4,128,416 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,430,869 | 4,159,264 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,463,912 | 4,168,394 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $23,811,599 | 4,274,973 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $38,819,033 | 3,591,030 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $86,777,991 | 4,134,254 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $97,423,068 | 3,057,849 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,539,108 | 816,343 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,014,827 | 158,274 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $3,510,367 | 194,265 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $3,400,216 | 197,802 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,628,419 | 118,344 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $844,762 | 105,070 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $932,269 | 133,563 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,140,924 | 75,458 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $734,879 | 33,495 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $261,231 | 9,686 | Shares | Defined | 2022-01-20 | |
| 2021-03-31 | $541,642 | 12,486 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,107,838 | 74,978 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||